Insights

Strategic Partnerships Aequus is actively expanding its pipeline through in-licensing and distribution agreements and aims to establish strategic partnerships to maximize global potential. This presents sales opportunities in co-promotion, distribution rights, and co-developed product initiatives across Canada and international markets.

Specialty Focus Targeted therapeutic areas include neurology, ophthalmology, and transplant, with a specific emphasis on improving medication adherence via enhanced delivery systems. Opportunities exist to position Aequus products with ophthalmology clinics, neurology/neuro-ophthalmology centers, transplant programs, and payer-focused access programs.

Canada-Centric Commercialization The company plans to commercialize internal programs in Canada and leverage partnerships for broader reach. Sales efforts can prioritize Canadian ophthalmology and neurology channels, engage with patient and physician groups, and align with provincial formulary and reimbursement pathways.

Recent Product Uptick ZIMED PF launched with reported early revenue, indicating momentum in ophthalmic therapies. This suggests an opportunity to upsell associated promotions, expand physician adoption, and explore neighboring glaucoma and ocular hypertension products or additional delivery mechanisms.

Operational Readiness Leadership emphasizes clinical development, regulatory processes, and efficient commercial strategy. This signals readiness for rapid onboarding of new product partnerships, scaled distribution agreements, and collaborative market-access initiatives with payers and providers.

Similar companies to Aequus Pharmaceuticals

Aequus Pharmaceuticals Tech Stack

Aequus Pharmaceuticals uses 8 technology products and services including Amazon Web Services, jsDelivr, Mailchimp, and more. Explore Aequus Pharmaceuticals's tech stack below.

Media & News

Aequus Pharmaceuticals's Email Address Formats

Aequus Pharmaceuticals uses at least 3 email formats:
Aequus Pharmaceuticals Email FormatsExamplePercentage
FLast@aequuspharma.caJDoe@aequuspharma.ca
84%
First.Last@aequuspharma.caJohn.Doe@aequuspharma.ca
10%
First@aequuspharma.caJohn@aequuspharma.ca
6%

Frequently Asked Questions

What is Aequus Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Aequus Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aequus Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's official website is aequuspharma.ca and has social profiles on LinkedIn and Crunchbase.

How much revenue does Aequus Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2026, Aequus Pharmaceuticals's annual revenue is estimated to be <$1M.

What is Aequus Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Aequus Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2026, Aequus Pharmaceuticals has approximately 1 employees across 1 continents, including North America. Key team members include Executive Clinical Specialist: D. F. and Research Analyst: I. P. Explore Aequus Pharmaceuticals's employee directory with LeadIQ.

What industry does Aequus Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Aequus Pharmaceuticals use?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's tech stack includes Amazon Web Services, jsDelivr, Mailchimp, Microsoft 365, Mapbox.js, Webflow, Datadog and GoDaddy.

What is Aequus Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals's email format typically follows the pattern of FLast@aequuspharma.ca. Find more Aequus Pharmaceuticals email formats with LeadIQ.

How much funding has Aequus Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2026, Aequus Pharmaceuticals has raised $14M in funding. The last funding round occurred on Jul 06, 2023 for $299K.

When was Aequus Pharmaceuticals founded?

Minus sign iconPlus sign icon
Aequus Pharmaceuticals was founded in 2013.
Aequus Pharmaceuticals logo

Aequus Pharmaceuticals

Pharmaceutical ManufacturingBritish Columbia, Canada0-1 Employees

Aequus Pharmaceuticals is a specialty pharmaceutical company based in Vancouver, British Columbia, focused on developing and commercializing differentiated products for niche therapeutic areas. Its Canadian sales and marketing activities target specialized segments, with a pipeline expanded through partnerships and the in-licensing of commercial-stage products. The company relies on input from patients, physicians, and payers to guide its programs, leveraging management experience in clinical development, regulatory approvals, and product marketing.

The firm’s therapeutic focus includes neurology, ophthalmology, and transplant, including efforts in neurology and psychiatry aimed at improving medication adherence through delivery innovations. A notable recent development is the August 2023 launch of Zimed PF in Canada, a product for reducing elevated intraocular pressure in open-angle glaucoma or ocular hypertension.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
0-1

Section iconFunding & Financials

  • $14M

    Aequus Pharmaceuticals has raised a total of $14M of funding over 8 rounds. Their latest funding round was raised on Jul 06, 2023 in the amount of $299K as a Post IPO Debt.

  • <$1M

    Aequus Pharmaceuticals's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.